SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NeurogesX, Inc. Partner Astellas Pharma Inc. Enrolls First Patient in EU Clinical Trial for QUTENZA(R) (8% Capsaicin Patch)